Antibiotic Innovation May Contribute to Slowing the Dissemination of Multiresistant Streptococcus pneumoniae : The Example of Ketolides

Lulla Opatowski, Laura Temime, Emmanuelle Varon et al. · 2008

Read Antibiotic Innovation May Contribute to Slowing the Dissemination of Multiresistant Streptococcus pneumoniae : The Example of Ketolides by Lulla Opatowski, Laura Temime, Emmanuelle Varon et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002089.txt.

Description

Lulla Opatowski and co-authors modeled whether a new drug class could slow resistant pneumococcus spread, in a 2008 PLOS ONE study. Streptococcus pneumoniae causes pneumonia and other ills, and its resistance to antibiotics keeps rising, yet new antibacterial classes are rare. Ketolides are one of the few new classes active against it in twenty-five years, and they act much like an older class.

The team modeled how ketolide use could affect the dissemination of multiresistant strains. As the title states, antibiotic innovation may contribute to slowing that spread. Models help stewards place a scarce new drug where it does the most good.

Catalog record

CREATORLulla Opatowski, Laura Temime, Emmanuelle Varon et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002089

Browse the full library · About the Tower of Babel